浅析肥胖糖尿病患者特征

目的：主要探究肥胖对Ⅰ型糖尿病影响,为Ⅰ型糖尿病的早期干预提供依据.方法：选择我院2009 年到2011 年间的入院患者共102 例,其中4 例为经典Ⅰ型糖尿病患者,9 例为成人隐匿性自身免疫性糖尿病（LADA）患者,89 例为Ⅱ型糖尿病患者.对其测量身高、体重,计算体质量指数并记录,然后测量糖化血红蛋白、空腹C 肽、空腹血糖、餐后2h 血糖、餐后2hC 肽、谷氨酸脱羧酶抗体、胰岛素、血脂.结果：经与非肥胖Ⅰ型糖尿病患者比较,肥胖Ⅰ型糖尿病易发生冠心病、高脂血症、合并代谢综合征,P〈0.05;空腹、餐后2h C 肽时水平高,P〈0.05;不易出现胰岛素依赖、糖尿病周围神经病变合并,P〈0.05;成人隐匿性自身免疫性糖尿病与肥胖经典Ⅰ型糖尿病比较,后者发病年龄较小,初诊空腹血糖水平较高,易发生酮症酸中毒、胰岛素依赖,P〈0.05;成人隐匿性自身免疫性糖尿病患者与非肥胖经典Ⅰ型糖尿病患者临床特点比较,后者发病年龄小、病程短、初诊时空腹血糖水平高,易出现酮症酸中毒及依赖胰岛素治疗情况,但糖尿病周围神经合并病变、视网膜病变发生几率小,P〈0.05.结论：肥胖性成人隐匿性自身免疫性糖尿病的临床特点同Ⅱ型糖尿病类似[1].

objective： to explore the main Ⅰ obesity in diabetes effects for Ⅰ diabetes early intervention, provides the basis. Method： choose from year 2009 to 2011 patients with a total of 102 patients were admitted to the hospital, 4 cases of classical Ⅰ for type Ⅰ diabetes, 9 cases of adult occult autoimmune diabetes （LADA） patients, 89 cases Ⅱ for type Ⅰ diabetes. The measuring height, weight, and body mass index calculation and record, and then measure glycated hemoglobin, fasting c-peptide, fasting blood sugar, blood sugar, 2 h after a meal after a meal 2 h C, glutamic acid peptide decarboxylation enzyme antibody, insulin, blood fat. Results： the Ⅰ with the obese patients with diabetes type comparison, obesity Ⅰ diabetes vulnerable to coronary heart disease, hyperlipidemia, with the metabolic syndrome, P 〈 0.05; After fasting, meal 2 h C peptide level when high, P 〈 0.05.